Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study-Reference-Cited by-同舟云学术

Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study

Published:2012-05 Issue: Volume:51 Page:206-215
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Salamone Stéphane,Colin Christelle,Grillier-Vuissoz Isabelle,Kuntz Sandra,Mazerbourg Sabine,Flament Stéphane,Martin Hélène,Richert Lysiane,Chapleur Yves,Boisbrun Michel

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

3. Herceptin: mechanisms of action and resistance

4. PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes

5. The PPARs: From Orphan Receptors to Drug Discovery

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pd-catalyzed room temperature hydrodeoxygenation of aryl sulfonates by tuning the stereoelectronic nature of ligands;Tetrahedron;2024-08

2. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors;Cancer Cell International;2024-04-10

3. Advances in Antitumor Effects Using Liposomal Citrinin in Induced Breast Cancer Model;Pharmaceutics;2024-01-26

4. Anticancer Drug Discovery By Structure-Based Repositioning Approach;Mini-Reviews in Medicinal Chemistry;2024-01

5. Claudin 1: An Emerging Target for Triple-Negative Breast Cancer;Interdisciplinary Cancer Research;2024